{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:32:51Z","timestamp":1787031171059,"version":"build-2736575974"},"reference-count":13,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,4]]},"DOI":"10.4269\/ajtmh.19-0841","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T03:01:15Z","timestamp":1600743675000},"page":"1930-1933","source":"Crossref","is-referenced-by-count":17,"title":["Case Report: Confirmation by Metagenomic Sequencing of Visceral Leishmaniasis in an Immunosuppressed Returned Traveler"],"prefix":"10.4269","volume":"103","author":[{"given":"Eloise","family":"Williams","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Austin Health, Heidelberg, Australia;"},{"name":"Department of Microbiology, Austin Health, Heidelberg, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole S.","family":"Isles","sequence":"additional","affiliation":[{"name":"Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Seemann","sequence":"additional","affiliation":[{"name":"Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Kilpatrick","sequence":"additional","affiliation":[{"name":"Department of Neurology, Royal Melbourne Hospital, Parkville, Australia;"},{"name":"Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, Australia;"},{"name":"The Florey Institute of Neuroscience and Mental Health, Parkville, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Grigg","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology, Austin Health, Heidelberg, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Leroi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Austin Health, Heidelberg, Australia;"},{"name":"Department of Infectious Diseases, Austin Health, Heidelberg, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin P.","family":"Howden","sequence":"additional","affiliation":[{"name":"Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, Australia;"},{"name":"Department of Infectious Diseases, Austin Health, Heidelberg, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Kwong","sequence":"additional","affiliation":[{"name":"Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, Australia;"},{"name":"Department of Infectious Diseases, Austin Health, Heidelberg, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"b2","doi-asserted-by":"crossref","first-page":"e0121418","DOI":"10.1371\/journal.pone.0121418","article-title":"Visceral leishmaniasis and immunocompromise as a risk factor for the development of visceral leishmaniasis: a changing pattern at the hospital for tropical diseases, London","volume":"10","author":"Fletcher","year":"2015","journal-title":"PLoS One"},{"key":"b3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"b4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.16-84256","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"96","author":"Aronson","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"b5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/1352458514555788","article-title":"Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient","volume":"21","author":"Artemiadis","year":"2015","journal-title":"Mult Scler"},{"key":"b6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N Engl J Med"},{"key":"b7","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.wnl.0000327609.57688.ea","article-title":"FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis","volume":"71","author":"Mehling","year":"2008","journal-title":"Neurology"},{"key":"b8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamaneurol.2014.3065","article-title":"Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management of varicella-zoster virus infections in MS","volume":"72","author":"Arvin","year":"2015","journal-title":"JAMA Neurol"},{"key":"b9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s13760-017-0794-7","article-title":"Multiple sclerosis treatment with fingolimod: profile of non-cardiologic adverse events","volume":"117","author":"Fragoso","year":"2017","journal-title":"Acta Neurol Belg"},{"key":"b10","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s11481-013-9465-5","article-title":"Fingolimod modulates peripheral effector and regulatory T cells in MS patients","volume":"8","author":"Serpero","year":"2013","journal-title":"J Neuroimmune Pharmacol"},{"key":"b11","doi-asserted-by":"crossref","first-page":"e0006647","DOI":"10.1371\/journal.pntd.0006647","article-title":"Sphingosine-1-phosphate signaling in Leishmania donavani infection in macrophages","volume":"12","author":"Arish","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"b12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2016.11.012","article-title":"Leishmania infections: molecular targets and diagnosis","volume":"57","author":"Akhoundi","year":"2017","journal-title":"Mol Aspects Med"},{"key":"b13","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3389\/fmicb.2017.01069","article-title":"Metagenomics: the next culture-independent game changer","volume":"8","author":"Forbes","year":"2017","journal-title":"Front Microbiol"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T12:42:52Z","timestamp":1611751372000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajtmh.org\/doi\/10.4269\/ajtmh.19-0841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11,4]]}},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.19-0841","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]}}}